A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT01031225 · COMPLETED
Trial details
- NCT number
- NCT01031225
- Sponsor
- Synta Pharmaceuticals Corp.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2013-07-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.